Horizon Therapeutics Public Limited Company Cash Conversion Cycle 2011-2026 | HZNP

Annual Cash Conversion Cycle Horizon Therapeutics Public Limited Company

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
107	127	113	147	164	168	237	112	90.2	59.2	32.5	-225

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
237	-225	94.3

Quarterly Cash Conversion Cycle Horizon Therapeutics Public Limited Company

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
101	93.6	-	62.7	67.2	143	-	138	156	253	80.8	117	158	170	103	144	149	169	138	151	160	197	152	156	147	196	89.9	134	108	115	78.5	84.8	111	115	65	89.8	102	79	48.4	60.4	131	102	49.7	50	82.3	106	61.4	793	162	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
793	48.4	132

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Alnylam Pharmaceuticals ALNY	46.6	$ 330.34	3.6 %	$ 43.3 B	USA
CollPlant Biotechnologies Ltd. CLGN	130	$ 0.44	-16.64 %	$ 5.04 M	Israel
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Catalyst Pharmaceuticals CPRX	120	$ 24.98	1.17 %	$ 3.05 B	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Cardiff Oncology CRDF	294	$ 1.58	-	$ 106 M	USA
Curis CRIS	103	$ 0.53	-3.07 %	$ 6.98 M	USA
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Crinetics Pharmaceuticals CRNX	-4.27 K	$ 37.7	1.26 %	$ 3.55 B	USA
CRISPR Therapeutics AG CRSP	1.1 K	$ 49.15	-0.73 %	$ 4.42 B	Schweiz
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	-1.92	-	1.93 %	$ 17.4 M	USA
CytomX Therapeutics CTMX	12.2	$ 4.4	-3.51 %	$ 607 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Cue Biopharma CUE	43.1	$ 0.18	-1.61 %	$ 17.1 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Aquestive Therapeutics AQST	-172	$ 4.09	-0.97 %	$ 437 M	USA
Cyclerion Therapeutics CYCN	120	$ 4.15	-32.52 %	$ 10.4 M	USA
Daré Bioscience DARE	-1.64 K	$ 1.81	4.02 %	$ 20.2 M	USA
DBV Technologies S.A. DBVT	71.3	$ 20.36	-3.32 %	$ 2.84 B	France
Arcturus Therapeutics Holdings ARCT	21.2	$ 8.22	2.37 %	$ 225 M	Israel
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Denali Therapeutics DNLI	1.89	$ 19.38	-6.15 %	$ 3.19 B	USA
Dyadic International DYAI	-26.6	$ 0.87	-2.8 %	$ 31.5 M	USA
AstraZeneca PLC AZN	-58	-	-	$ 96.9 B	Britain
Celldex Therapeutics CLDX	-3.74 K	$ 31.37	1.0 %	$ 2.08 B	USA